Update zur Diagnostik und Therapie der Synkope

Literatur

• 1 Linzer M, Yang E H, Estes N A , Wang P, Vorperian V R, Kapoor W N. Diagnosing syncope. 1. Value of history, physical examination, and electrocardiography: Clinical Efficacy Assessment Project of the American College of Physicians.  Ann Intern Med. 1997;  126 989-996
• 2 Soteriadis E S, Evans J C, Larson M G, Chen M H, Chen L, Benjamin E J, Levy D. Incidence and prognosis of syncope.  N Engl J Med. 2002;  347 878-885
• 3 Linzer M, Pontinen M, Gold D T, Divine G W, Felder A, Brooks W B. Impairment of physical and psychological function in recurrent syncope.  J Clin Epidemiol. 1991;  44 1037-1043
• 4 Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc J J, Bloch Thomsen P E. et al . Guidelines on management (diagnosis and treatment) of syncope.  Eur Heart J. 2001;  22 1256-1306
• 5 Brignole M, Alboni P, Benditt D G, Bergfeldt L, Blanc J J, Bloch Thomsen P E. et al . Guidelines on management (diagnosis and treatment) of syncope - update 2004.  Eur Heart J. 2004;  25 2054-2072
• 6 Ector H, Reybrouck T, Heidbuchel H. Tilt training: a new treatment for recurrent neurocardiogenic syncope or severe orthostatic intolerance.  Pacing Clin Electrophysiol. 1998;  21 193-196
• 7 Brignole M, Croci F, Menozzi C. Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope.  J Am Coll Cardiol. 2002;  40 2054-2060
• 8 Madrid A, Ortega I, Rebollo G J. Lack of efficacy of atenolol for the prevention of neurally-mediated syncope in highly symptomatic population: a prospective double-blind, randomized and placebo-controlled study.  J Am Coll Cardiol. 2001;  37 554-557
• 9 Connolly S, Sheldon R, Thorpe K E, Roberts R S, Ellenbogen K A, Wilkoff B L, Morillo C, Gent M. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial.  JAMA. 2003;  289 2224-2229
• 10 Moss A J, Zareba W, Hall W J, Klein H, Wilber D J, Cannom D S. et al . Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.  N Engl J Med. 2002;  346 877-883
• 11 Bardy G H, Lee K L, Mark D B, Poole J E, Packer D L, Boineau R. et al . Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.  N Engl J Med. 2005;  352 225-236
• 12 Krahn A D, Klein G J, Norris C, Yee R. The etiology of syncope in patients with negative tilt table and electrophysiological testing.  Circulation. 1995;  92 1819-1824
• 13 Brignole M, Menozzi C, Moya A, Garcia-Civera R, Mont L, Alvarez M. et al . Mechanism of syncope in patients with bundle branch block and negative electrophysiological test.  Circulation. 2001;  104 2045-2050
• 14 Krahn A D, Klein G J, Yee R, Hoch J S, Skanes A C. Cost implications of testing strategy in patients with syncope.  J Am Coll Cardiol. 2003;  42 495-501
• 15 Drew B J, Califf R M, Funk M, Kaufman E S, Krucoff M W, Laks M M. et al . Practice standards for electrocardiographic monitoring in hospital settings.  Circulation. 2004;  110 2721-2746